BRANFORD, Conn., Aug. 25, 2009 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) announced today a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the labeling for its FORE-SIGHT(r) Cerebral Oximeter. The new labeling allows FORE-SIGHT to be used on all patients, including those weighing less than 2.5 Kilograms (kg).
